erythromycin has been researched along with Diabetic Nephropathies in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Makino, H; Nagase, R; Nishishita, S; Ogawa, D; Ohga, S; Okada, S; Sasaki, M; Shikata, K; Shikata, Y; Tone, A; Usui, H; Wada, J; Yozai, K | 1 |
| Gayowski, T; Muder, RR; Singh, N; Yu, VL | 1 |
| Gallar, P; Guijo, G; Oliet, A; Ortega, O; Vigil, A | 1 |
| Ralston, RA; Rao, KV | 1 |
4 other study(ies) available for erythromycin and Diabetic Nephropathies
| Article | Year |
|---|---|
Erythromycin ameliorates renal injury via anti-inflammatory effects in experimental diabetic rats.
Topics: Albuminuria; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemokine CCL2; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Erythromycin; Intercellular Adhesion Molecule-1; Kidney; Macrophages; NF-kappa B; Rats; Rats, Sprague-Dawley; Streptozocin; Transcription Factor RelA; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2005 |
Legionella infection in liver transplant recipients: implications for management.
Topics: Adult; Ciprofloxacin; Diabetic Nephropathies; Drug Therapy, Combination; Erythromycin; Female; Hepatitis, Viral, Human; Humans; Legionellosis; Legionnaires' Disease; Liver Transplantation; Male; Middle Aged; Opportunistic Infections | 1993 |
Intraperitoneal erythromycin for diabetic gastroparesis in CAPD.
Topics: Adult; Diabetic Nephropathies; Erythromycin; Female; Humans; Peritoneal Dialysis, Continuous Ambulatory; Stomach Diseases | 1992 |
Meningitis due to Campylobacter fetus intestinalis in a kidney transplant recipient. A case report.
Topics: Campylobacter fetus; Campylobacter Infections; Chloramphenicol; Diabetic Nephropathies; Erythromycin; Humans; Kidney Transplantation; Male; Meningitis; Mexico; Middle Aged | 1987 |